Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Z-Bum
- Development stage
- Unknown
- Lead developer
- GM Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Z-Bum is an over-the-counter (OTC) topical cream developed and distributed by GM Pharmaceuticals for the treatment and prevention of diaper rash. The formulation contains 22% zinc oxide, which serves as a skin protectant by creating a physical barrier that shields the skin from moisture and external irritants. In addition to the active ingredient, the cream incorporates aloe barbadensis leaf juice and vitamin E (tocopheryl acetate) to provide soothing and moisturizing effects. It is marketed as a non-greasy, non-irritating, and non-comedogenic product suitable for protecting chafed skin associated with diaper use.
- Brand names
- Z-BumZ-Bum Diaper Rash Cream
Beyond the preview
Go deeper on Z-Bum.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Z-Bum.